• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

液体活检在肺多形性癌中的应用前景:病例报告

Liquid biopsy perspectives in pleomorphic carcinoma of the lung: case report.

作者信息

Rossi Tania, Cortesi Michela, Zanoni Michele, Bandini Sara, Sbrighi Camilla, Angeli Davide, Masciale Valentina, Grisendi Giulia, Costantini Matteo, Stella Franco, Ulivi Paola, Aramini Beatrice

机构信息

Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.

出版信息

Transl Lung Cancer Res. 2025 Jun 30;14(6):2324-2336. doi: 10.21037/tlcr-2024-1275. Epub 2025 Jun 19.

DOI:10.21037/tlcr-2024-1275
PMID:40673099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12261257/
Abstract

BACKGROUND

Liquid biopsy has recently made it possible to use minimally invasive testing to examine tumor-derived material released into peripheral blood, including circulating tumor cells (CTCs), extracellular vesicles (EVs), and circulating tumor deoxyribonucleic acid (ctDNA). Lung pleomorphic carcinoma (PC) is an extremely rare and severe form of cancer. Although resection tissues are the basis for PC diagnosis in everyday practice, tiny biopsies and cytologic specimens might potentially raise suspicions. Because PC may show varied expression of conventional carcinoma markers, it can be particularly challenging to differentiate sarcomatoid (i.e., spindle cell or giant cell) components from other tumor forms, such as sarcomatoid mesothelioma and other sarcomas. We think that defining a more specific context to better understand patient prognosis may be aided by the discovery of blood molecular markers in PC.

CASES DESCRIPTION

We present two cases of patients underwent major lung resection at our center with a diagnosis of PC of the lung; specifically, according with 8th TNM edition, case 1 showed a final pathological stage pathological tumor-node-metastasis (pTNM): pT1cN0G3LV0R0, and case 2 showed a stage pTNM: pT3N0G3LV0R0. Patients were both discharged after surgery with no postoperative complications. Oncologists suggested a 5-year clinical and radiological follow-up, however case 1 patient is free from recurrence at the moment, while case 2 patient died for brain recurrence 10 months after surgery. Immediately after surgical resection, patient's specimens were sent to the pathology unit. The pathologist, without affecting the accuracy of histological diagnosis, selected representative tissue samples and sent them at 4 ℃ in specific media, to Bioscience Laboratory, IRCCS IRST "Dino Amadori" for tissue analysis. Additionally, blood samples collected before surgery were sent for the characterization of CTCs and EVs.

CONCLUSIONS

To better characterize the potential relationship between the presence of CTCs, EVs and high grade of malignancy and any subsequent connection to death and/or recurrence, we think that liquid biopsy, which involves the identification and characterization of tumor-derived elements, may serve as future approach and tool not only in NSCLC but also in each specific histotype as for lung PC.

摘要

背景

液体活检最近使得通过微创检测来检查释放到外周血中的肿瘤衍生物质成为可能,这些物质包括循环肿瘤细胞(CTC)、细胞外囊泡(EV)和循环肿瘤脱氧核糖核酸(ctDNA)。肺多形性癌(PC)是一种极其罕见且严重的癌症形式。虽然在日常实践中切除组织是PC诊断的基础,但微小活检和细胞学标本可能会引发怀疑。由于PC可能表现出传统癌标志物的不同表达,因此将肉瘤样(即梭形细胞或巨细胞)成分与其他肿瘤形式(如肉瘤样间皮瘤和其他肉瘤)区分开来可能特别具有挑战性。我们认为,发现PC中的血液分子标志物可能有助于定义一个更具体的背景,以更好地了解患者的预后。

病例描述

我们展示了两例在我们中心接受肺大切除术并被诊断为肺PC的患者;具体而言,根据第8版TNM分期,病例1的最终病理分期为病理肿瘤-淋巴结-转移(pTNM):pT1cN0G3LV0R0,病例2的分期为pTNM:pT3N0G3LV0R0。两名患者术后均顺利出院,无术后并发症。肿瘤学家建议进行5年的临床和影像学随访,然而病例1的患者目前无复发,而病例2的患者在术后10个月因脑转移死亡。手术切除后,立即将患者的标本送往病理科。病理学家在不影响组织学诊断准确性的情况下,选择代表性组织样本,并在4℃下用特定培养基将其送往IRCCS IRST“迪诺·阿马多里”生物科学实验室进行组织分析。此外,术前采集的血样被送去进行CTC和EV的特征分析。

结论

为了更好地表征CTC、EV的存在与高恶性程度之间的潜在关系以及与任何后续死亡和/或复发的联系,我们认为,涉及肿瘤衍生成分鉴定和表征的液体活检不仅可作为未来非小细胞肺癌(NSCLC)的方法和工具,也可用于肺PC等每种特定组织学类型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/80d70bf30652/tlcr-14-06-2324-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/c579ecb5c856/tlcr-14-06-2324-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/9b0858a4246b/tlcr-14-06-2324-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/4b64a5fbffa4/tlcr-14-06-2324-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/6b20340e2ed0/tlcr-14-06-2324-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/80d70bf30652/tlcr-14-06-2324-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/c579ecb5c856/tlcr-14-06-2324-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/9b0858a4246b/tlcr-14-06-2324-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/4b64a5fbffa4/tlcr-14-06-2324-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/6b20340e2ed0/tlcr-14-06-2324-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad78/12261257/80d70bf30652/tlcr-14-06-2324-f5.jpg

相似文献

1
Liquid biopsy perspectives in pleomorphic carcinoma of the lung: case report.液体活检在肺多形性癌中的应用前景:病例报告
Transl Lung Cancer Res. 2025 Jun 30;14(6):2324-2336. doi: 10.21037/tlcr-2024-1275. Epub 2025 Jun 19.
2
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
3
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
9
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

本文引用的文献

1
Liquid biopsy in cancer current: status, challenges and future prospects.癌症液体活检的现状、挑战与未来前景
Signal Transduct Target Ther. 2024 Dec 2;9(1):336. doi: 10.1038/s41392-024-02021-w.
2
Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies.癌症中的细胞外囊泡:机制、生物标志物及治疗策略
MedComm (2020). 2024 Nov 28;5(12):e70009. doi: 10.1002/mco2.70009. eCollection 2024 Dec.
3
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.小细胞肺癌分子特征和治疗靶点的新进展。
Nat Rev Clin Oncol. 2024 Aug;21(8):610-627. doi: 10.1038/s41571-024-00914-x. Epub 2024 Jul 4.
4
Dual-Recognition-Mediated Autocatalytic Amplification Assay for the Subpopulations of PD-L1 Positive Extracellular Vesicle.基于双重识别介导的自动催化扩增检测方法用于 PD-L1 阳性细胞外囊泡亚群的分析。
Anal Chem. 2024 Jun 11;96(23):9585-9592. doi: 10.1021/acs.analchem.4c01111. Epub 2024 May 30.
5
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.癌症生物标志物:个性化治疗的新兴趋势和临床意义。
Cell. 2024 Mar 28;187(7):1617-1635. doi: 10.1016/j.cell.2024.02.041.
6
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer.循环肿瘤细胞:在晚期非小细胞肺癌中的检测与应用。
Int J Mol Sci. 2023 Nov 8;24(22):16085. doi: 10.3390/ijms242216085.
7
Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling.COPD 患者来源的细胞外囊泡通过 HIF-1α 转移调节癌症起始细胞表型。
Cell Death Dis. 2023 Oct 14;14(10):681. doi: 10.1038/s41419-023-06212-1.
8
Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I-IIIA NSCLC.在接受手术治疗的 I-IIIA 期非小细胞肺癌患者围手术期采用循环肿瘤细胞进行监测。
Transl Lung Cancer Res. 2023 Jul 31;12(7):1414-1424. doi: 10.21037/tlcr-22-827. Epub 2023 Jun 21.
9
Significance of circulating tumor cells in lung cancer: a narrative review.循环肿瘤细胞在肺癌中的意义:一篇叙述性综述。
Transl Lung Cancer Res. 2023 Apr 28;12(4):877-894. doi: 10.21037/tlcr-22-712. Epub 2023 Mar 29.
10
Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial.奥希替尼作为可切除 II-IIIB 期 EGFR 突变肺腺癌患者的新辅助治疗(NEOS):一项多中心、单臂、开放标签的 2b 期临床试验。
Lung Cancer. 2023 Apr;178:151-156. doi: 10.1016/j.lungcan.2023.02.011. Epub 2023 Feb 17.